Evidence map›Paper›PMID 26300211›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2015

Evolution of a Unified Strategy for Complex Sesterterpenoids: Progress toward Astellatol and the Total Synthesis of (-)-Nitidasin.

Daniel T Hog, Florian M E Huber, Gonzalo Jiménez-Osés, Peter Mayer, Kendall N Houk, Dirk Trauner

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Studies towards the Synthesis of (+)-Dictyoxetane.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  2. Synthetic study toward the diterpenoid aberrarone.Beilstein journal of organic chemistry · 2022
    Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel T HogDepartment for Chemistry and Center of Integrated Protein Science, Ludwig-Maximilians-Universität München, Butenandstr. 5-13, 81377 München (Germany).
Florian M E HuberDepartment for Chemistry and Center of Integrated Protein Science, Ludwig-Maximilians-Universität München, Butenandstr. 5-13, 81377 München (Germany).
Gonzalo Jiménez-OsésDepartment of Chemistry and Biochemistry, University of California, 607 Charles E. Young Drive East, Los Angeles, CA 90095 (USA). gjimenez@chem.ucla.edu.
Peter MayerDepartment for Chemistry and Center of Integrated Protein Science, Ludwig-Maximilians-Universität München, Butenandstr. 5-13, 81377 München (Germany).
Kendall N HoukDepartment of Chemistry and Biochemistry, University of California, 607 Charles E. Young Drive East, Los Angeles, CA 90095 (USA).
Dirk TraunerDepartment for Chemistry and Center of Integrated Protein Science, Ludwig-Maximilians-Universität München, Butenandstr. 5-13, 81377 München (Germany). Dirk.Trauner@cup.uni-muenchen.de.

Funding

Design of New Enzyme CatalystsR01GM075962 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOUK, KENDALL N · 2009 to 2012
$1.2M
NIGMS NIH HHS GM075962NIGMS NIH HHS R01 GM075962
6 · The paper itself

Abstract

Astellatol and nitidasin belong to a subset of sesterterpenoids that share a sterically encumbered trans-hydrindane motif with an isopropyl substituent. In addition, these natural products feature intriguing polycyclic ring systems, posing significant challenges for chemical synthesis. Herein, the evolution of our stereoselective strategy for isopropyl trans-hydrindane sesterterpenoids is detailed. These endeavors included the synthesis of several building blocks, enabling studies toward all molecules of this terpenoid subclass, and of advanced intermediates of our initial route toward a biomimetic synthesis of astellatol. These findings provided the basis for a second-generation and a third-generation approach toward astellatol that eventually culminated in the enantioselective total synthesis of (-)-nitidasin. In particular, a series of substrate-controlled transformations to install the ten stereogenic centers of the target molecule was orchestrated and the carbocyclic backbone was forged in a convergent fashion. Furthermore, the progress toward the synthesis of astellatol is disclosed and insights into some observed yet unexpected diastereoselectivities by detailed quantum-mechanical calculations are provided.

Indexed as

Biological ProductsBiomimeticsMolecular StructureSesquiterpenesSesterterpenesStereoisomerismastellatolBiological ProductsnitidasinSesquiterpenesSesterterpenescomputational chemistrynatural productsstereoselective synthesisterpenoidstotal synthesis

Identifiers

PMID26300211
PMCPMC4696511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.